(All four clinical treatment groups of breast cancer we have analyzed (HR+/HER2- tumors, HR-/HER2+ tumors, HR+/HER2+ tumors, and TN breast tumors) expressed similar densities of tumor peripheral FSHR+ blood vessels). This evidence concerns the gene FSHR and breast neoplasm.